Australia markets closed

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
48.55+1.61 (+3.43%)
At close: 04:00PM EDT
48.55 0.00 (0.00%)
After hours: 04:00PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
246,171
171,546
187,802
195,892
213,312
Cost of revenue
59,080
42,180
45,465
60,897
61,916
Gross profit
187,091
129,366
142,337
134,995
151,396
Operating expenses
Research development
43,095
51,275
30,785
36,810
44,419
Selling general and administrative
77,625
75,322
78,598
76,370
60,509
Total operating expenses
120,720
126,597
109,383
113,180
104,928
Operating income or loss
66,371
2,769
32,954
21,815
46,468
Interest expense
1,579
1,635
2,577
2,686
2,736
Total other income/expenses net
-13,699
-6,242
-8,262
700
-9,852
Income before tax
51,772
-4,548
22,677
21,998
34,038
Income tax expense
15,920
4,079
10,688
7,685
2,135
Income from continuing operations
35,852
-8,627
11,989
14,313
31,903
Net income
35,852
-8,627
11,989
14,313
31,903
Net income available to common shareholders
35,852
-8,627
11,989
14,313
31,903
Basic EPS
-
-
0.89
1.04
2.16
Diluted EPS
-
-
0.87
1.01
2.09
Basic average shares
-
-
13,482
13,755
14,769
Diluted average shares
-
-
13,771
14,139
15,279
EBITDA
-
847
30,020
29,335
40,444